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background:  In the present study we tested the hypothesis that age modulates the impact of HbA1c on cardiovascular event risk in 
patients with established coronary artery disease (CAD).
Methods:  We prospectively recorded cardiovascular events over a mean follow-up period of 4.4±1.2 years in a large consecutive series of 
816 patients with angiographically proven CAD, including 376 subjects <65 years and 440 subjects ≥65 years.
Results:  During follow-up, the incidence of cardiovascular events was 9.3% among subjects <65 years and 24.8% among subjects ≥65 
years (p<0.001). Among the younger patients, HbA1c strongly and significantly predicted cardiovascular events (HR 1.54 [1.06-2.23]; 
p=0.022), but not among in the older patients (HR 1.22 [0.94-1.59]; p=0.125). An interaction term age x HbA1c was statistically significant 
(p=0.007), indicating that HbA1c was a significantly stronger predictor of cardiovascular events among younger than among older CAD 
patients.
conclusion:  We conclude that HbA1c is a significantly stronger predictor of cardiovascular events in younger patients than in older 
patients with established CAD.
